Therapeutic implications of peroxisome proliferator-activated receptors in non-small cell lung cancer
{{output}}
Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 80-85% of cases. Despite therapeutic advances, drug resistance and suboptimal outcomes persist, underscoring the n... ...